We are live on
!
Find out more
Ninety One (UK) Portfolio holdings
AUM
$44.7B
1-Year Est. Return
17.24%
This Fund
S&P 500
This Quarter
Est. Return
+2.53%
1 Year Est. Return
+17.24%
3 Year Est. Return
+87.79%
5 Year Est. Return
+111.34%
10 Year Est. Return
+534.1%
AUM
$13B
AUM Growth
–
Cap. Flow
+$13.1B
Cap. Flow
% of AUM
100.6%
Top 10 Holdings %
Top 10 Hldgs %
20.89%
Holding
229
New
229
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Pfizer
PFE
|
+$412M |
| 2 |
Valero Energy
VLO
|
+$301M |
| 3 |
Signet Jewelers
SIG
|
+$300M |
| 4 |
Microsoft
MSFT
|
+$282M |
| 5 |
Cisco
CSCO
|
+$269M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Energy | 16.94% |
| 2 | Healthcare | 16.38% |
| 3 | Financials | 15.27% |
| 4 | Technology | 13.02% |
| 5 | Consumer Discretionary | 7.54% |
Similar funds
AS
LP
Ninety One (UK)'s Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Ninety One (UK), which disclosed 229 positions worth $13B. Its ten largest holdings account for 21% of the portfolio.
Its largest position is Pfizer: 14,904,007 shares worth $396M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, followed by Healthcare and Financials.
- Ninety One (UK)'s largest Q2 2013 buy was Pfizer: 14,904,007 shares worth $396M.
- Ninety One (UK)'s ten largest holdings make up 21% of its $13B portfolio in Q2 2013.
- Ninety One (UK) disclosed 229 positions in Q2 2013, its first 13F filing on record.
Based on Ninety One (UK)'s 13F filing for Q2 2013, filed 12 Aug 2013.